May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
Retrospective Review Of Methotrexate Therapy In Treatment Of Chronic Noninfectious Scleritis
Author Affiliations & Notes
  • A.W. Jachens
    Ophthalmology, UMDNJ – NJMS, Newark, NJ
  • D.S. Chu
    Ophthalmology, UMDNJ – NJMS, Newark, NJ
  • Footnotes
    Commercial Relationships  A.W. Jachens, None; D.S. Chu, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 591. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A.W. Jachens, D.S. Chu; Retrospective Review Of Methotrexate Therapy In Treatment Of Chronic Noninfectious Scleritis . Invest. Ophthalmol. Vis. Sci. 2006;47(13):591.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To determine the efficacy and safety of methotrexate in the treatment of chronic noninfectious scleritis.

Methods: : We conducted a retrospective chart review of all patients treated for scleritis between January 2000 and July 2005 at the Institute of Ophthalmology and Visual Science at the University of Medicine and Dentistry of New Jersey. Patients who were treated with methotrexate therapy were included in the study in order to assess the ability of methotrexate to control inflammation and reduce steroid usage.

Results: : The 18 patients included in the study consisted of 15 female and 3 male, with a mean age of 46 years. The control of inflammation was achieved in 11 patients (61%), with 7 patients quiescent for more then a year. The sparing of steroids was achieved in 14 patients (78%), with 6 patients completely discontinuing steroid use. Visual acuity was maintained or improved in 86% of patients. Side effects leading to the discontinuation of methotrexate occurred in one patient (6%). There were no serious adverse reactions nor long–term morbidity or mortality caused by methotrexate.

Conclusions: : Methotrexate is an effective and well tolerated therapy which can reduce inflammation and decrease steroid usage in the treatment of chronic, noninfectious scleritis.

Keywords: sclera • autoimmune disease • inflammation 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.